It's a fairly common type of transaction for smaller companies. The warrants act as a 'sweetener' to attract buyers. NCI is selling (best efforts) 4.5M units at $2.20 to raise $10M. Each unit is one share and one-half warrant. A full warrant can buy a new share at $2.95 with a two-year expiry. If the company needs money, there will be dilution. But considering that units are $2.20, and the warrant exercise price, NCI is raising money at a higher price than its shares in the market ($2.12) which we would consider not so bad. Yes of course if shares go to $4 the company would be better off selling 'then' but small companies need money sooner rather than later, and often need to raise money when they can, rather than a perfect time. In addition, shares are up 150% in the past year and its last financing was at $1.40/share last September. As far as small cap financings go, we would not consider it a bad transaction.
5i Research Answer: